In this panel discussion, key experts from AstraZeneca, Oxford Biomedic & Novartis, explore how technological advancements are poised to revolutionise laboratory operations, as well as discuss the challenges associated with injecting emerging technology into a legacy environment.
Please note: That all fields marked with an asterisk (*) are required.